• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A Temporizing Solution to "Artemisinin Resistance".

作者信息

Wang Jigang, Xu Chengchao, Liao Fu Long, Jiang Tingliang, Krishna Sanjeev, Tu Youyou

机构信息

From the Artemisinin Research Center and the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing (J.W., C.X., F.L.L., T.J., Y.T.), and the ShenZhen People's Hospital, ShenZhen (J.W., C.X.) - both in China; the Department of Pharmacology and Biological Sciences, National University of Singapore, Singapore (J.W., C.X.); the Centre for Diagnostics and Antimicrobial Resistance, Institute for Infection and Immunity, St. George's University of London and St. George's University Hospitals NHS Foundation Trust, London (S.K.); and the Institut für Tropenmedizin, Universitätsklinikum Tübingen, Tübingen, Germany (S.K.).

出版信息

N Engl J Med. 2019 May 30;380(22):2087-2089. doi: 10.1056/NEJMp1901233. Epub 2019 Apr 24.

DOI:10.1056/NEJMp1901233
PMID:31018065
Abstract
摘要

相似文献

1
A Temporizing Solution to "Artemisinin Resistance".针对“青蒿素耐药性”的一种临时解决方案。
N Engl J Med. 2019 May 30;380(22):2087-2089. doi: 10.1056/NEJMp1901233. Epub 2019 Apr 24.
2
Artemisinin resistance, some facts and opinions.青蒿素耐药性：一些事实与观点
J Infect Dev Ctries. 2015 Jul 4;9(6):597-9. doi: 10.3855/jidc.7015.
3
The threat of artemisinin resistant malaria in Southeast Asia.东南亚青蒿素耐药性疟疾的威胁。
Travel Med Infect Dis. 2016 Nov-Dec;14(6):548-550. doi: 10.1016/j.tmaid.2016.11.016. Epub 2016 Nov 30.
4
Malaria. Signs of drug resistance rattle experts, trigger bold plan.疟疾。耐药迹象令专家们不安，引发大胆计划。
Science. 2008 Dec 19;322(5909):1776. doi: 10.1126/science.322.5909.1776.
5
Curcumin-artemisinin combination therapy for malaria.姜黄素-青蒿素联合疗法治疗疟疾。
Antimicrob Agents Chemother. 2006 May;50(5):1859-60. doi: 10.1128/AAC.50.5.1859-1860.2006.
6
Drug development: Holding out for reinforcements.药物研发：期待援军
Nature. 2012 Apr 25;484(7395):S16-8. doi: 10.1038/484S16a.
7
Artemisinin Bioactivity and Resistance in Malaria Parasites.青蒿素在疟原虫中的生物活性与抗药性。
Trends Parasitol. 2019 Dec;35(12):953-963. doi: 10.1016/j.pt.2019.09.005. Epub 2019 Nov 4.
8
Artemisinins: activities and actions.青蒿素：活性与作用
Microbes Infect. 2004 Nov;6(14):1339-46. doi: 10.1016/j.micinf.2004.09.002.
9
If artemisinin drugs fail, what's plan B?如果青蒿素类药物失效，备用方案是什么？
Science. 2010 May 14;328(5980):846. doi: 10.1126/science.328.5980.846.
10
Plasmodium sensitivity to artemisinins: magic bullets hit elusive targets.疟原虫对青蒿素类药物的敏感性：神奇子弹击中难以捉摸的目标。
Trends Parasitol. 2011 Feb;27(2):73-81. doi: 10.1016/j.pt.2010.11.006. Epub 2010 Dec 18.

引用本文的文献

1
Artemether-Lumefantrine Treatment Selects Plasmodium falciparum Multidrug Resistance 1 (pfmdr1) Increased Copy Number Among African Malaria Infections.蒿甲醚-本芴醇治疗在非洲疟疾感染中选择了恶性疟原虫多药耐药性1（pfmdr1）拷贝数增加的情况。
J Infect Dis. 2025 Jul 11;231(6):e1119-e1128. doi: 10.1093/infdis/jiaf155.
2
Gefitinib as an antimalarial: unveiling its therapeutic potential.吉非替尼作为一种抗疟药物：揭示其治疗潜力。
Inflammopharmacology. 2025 Mar;33(3):1357-1379. doi: 10.1007/s10787-025-01682-5. Epub 2025 Feb 28.
3
The spatiotemporal transcriptional profiling of murine brain during cerebral malaria progression and after artemisinin treatment.
小鼠脑在脑型疟疾进展过程中和青蒿素治疗后的时空转录谱分析。
Nat Commun. 2025 Feb 11;16(1):1540. doi: 10.1038/s41467-024-52223-7.
4
Inaccurate communication in health sciences: The case of 'partial artemisinin resistance' for the treatment of malaria.健康科学中的不准确沟通：以疟疾治疗中“部分青蒿素抗性”为例。
New Microbes New Infect. 2024 Nov 30;62:101544. doi: 10.1016/j.nmni.2024.101544. eCollection 2024 Dec.
5
Photoaffinity probe-based antimalarial target identification of artemisinin in the intraerythrocytic developmental cycle of .基于光亲和探针的青蒿素在疟原虫红细胞内发育周期中的抗疟靶点鉴定 。 你提供的原文似乎不完整，句末的“of.”后面缺少具体内容。
Imeta. 2024 Feb 19;3(2):e176. doi: 10.1002/imt2.176. eCollection 2024 Apr.
6
Efficacies and ADME properties of redox active methylene blue and phenoxazine analogues for use in new antimalarial triple drug combinations with amino-artemisinins.氧化还原活性亚甲蓝和吩恶嗪类似物与氨基青蒿素用于新型抗疟三联药物组合的有效性及药代动力学性质。
Front Pharmacol. 2024 Jan 8;14:1308400. doi: 10.3389/fphar.2023.1308400. eCollection 2023.
7
Combined chemical transformation and biological transformation of artemisinin: A facile approach to diverse artemisinin derivatives.青蒿素的化学转化与生物转化相结合：一种制备多种青蒿素衍生物的简便方法。
Front Chem. 2023 Jan 24;10:1089290. doi: 10.3389/fchem.2022.1089290. eCollection 2022.
8
Polymorphisms in the K13-Propeller Gene in Artemisinin-Resistant in Mice.青蒿素抗性小鼠中K13螺旋桨基因的多态性
Infect Drug Resist. 2022 Nov 8;15:6533-6544. doi: 10.2147/IDR.S383127. eCollection 2022.
9
The Impact of Extended Treatment With Artemether-lumefantrine on Antimalarial Exposure and Reinfection Risks in Ugandan Children With Uncomplicated Malaria: A Randomized Controlled Trial.青蒿琥酯-咯萘啶延长疗程对乌干达无并发症疟疾儿童抗疟药物暴露和再感染风险的影响：一项随机对照试验。
Clin Infect Dis. 2023 Feb 8;76(3):443-452. doi: 10.1093/cid/ciac783.
10
Selective Inhibition of Plasmodium falciparum ATPase 6 by Artemisinins and Identification of New Classes of Inhibitors after Expression in Yeast.青蒿素类药物对疟原虫 ATP 酶 6 的选择性抑制作用及在酵母中表达后的新型抑制剂的鉴定。
Antimicrob Agents Chemother. 2022 May 17;66(5):e0207921. doi: 10.1128/aac.02079-21. Epub 2022 Apr 25.